1 / 14

Active Pharmaceutical ingredient FOR GENERICS

Active Pharmaceutical ingredient FOR GENERICS. Presented By: Dr. Zeba Ahmed Shuja Director Technical, Schazoo Zaka Pvt. Ltd. Active Pharmaceutical ingredient. WHO Requirements: API: API Name Nomenclature Recommended INN Compendial name Chemical name Other non proprietary name

ermin
Download Presentation

Active Pharmaceutical ingredient FOR GENERICS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Active Pharmaceutical ingredient FOR GENERICS Presented By: Dr. Zeba Ahmed Shuja Director Technical, Schazoo Zaka Pvt. Ltd.

  2. Active Pharmaceutical ingredient WHO Requirements: API: • API Name • Nomenclature • Recommended INN • Compendial name • Chemical name • Other non proprietary name • CAS registry number DRAP Requirements: API: • API Name • No information required regarding chemical name etc.

  3. Active Pharmaceutical ingredient WHO Requirements: • API Structure • Structural formula • Molecular formula • Molecular weight • General properties • Physical description • Solubility • Physical form • Stereochemistry polymorphism DRAP Requirements: • No information is required regarding structure of the API, Molecular formula, or stereochemistry or polymorphism.

  4. Active Pharmaceutical ingredient WHO Requirements: • Control of API • API specifications of API and FPP manufacturer • Container/ Closure system DRAP Requirements: • API specifications of FPP manufacturer is required • No information required regarding container/closure system.

  5. Active Pharmaceutical ingredient WHO Requirements: • Stability of API • Stability summary & conclusion • Proposed storage condition & retest period DRAP Requirements: • No data regarding stability of the API is required like stability summary, proposed storage condition etc of the API.

  6. Active Pharmaceutical ingredient WHO Requirements: • API Manufacturer • Name, address & responsibility (certificate of suitability , API master file) • Manufacturing authorization for production of API • Description of manufacturing process and process controls DRAP Requirements: • No information regarding API manufacturing and manufacturing process is required.

  7. Active Pharmaceutical ingredient • WHO Requirements: • Manufacturing process flow diagram • Brief description of the manufacturing process DRAP Requirements: • No flow diagram, or description of the manufacturing process is required.

  8. Active Pharmaceutical ingredient WHO Requirements: • Control of Materials • Summary of the quality and controls of the starting materials • Name and manufacturing site address of starting material manufacturer(s): DRAP Requirements: • No information related to control of materials, Summary of the quality and controls of the starting materials is required etc

  9. Active Pharmaceutical ingredient WHO Requirements: • Controls of Critical Steps and Intermediates • Process Validation and/or Evaluation • Manufacturing Process Development DRAP Requirements: • No information related to control of critical steps & intermediates, process validation, manufacturing process development etc.

  10. Active Pharmaceutical ingredient WHO Requirements: • Characterisation • Elucidation of Structure and other Characteristics by IR, NMR or Mass spectroscopy. • Control of the API • Specification (API Specs of FPP manufacturer) DRAP Requirements: • No characterization data required as elucidation of structure, control of APIs, Analytical procedures, validation of analytical procedures etc.

  11. Active Pharmaceutical ingredient WHO Requirements: • Validation of Analytical Procedure of API, • Validation of related substances, residual/impurities solvents of API • Batch Analyses of three consecutive batches DRAP Requirements: • Analytical method validation or batch analysis is not required

  12. Active Pharmaceutical ingredient WHO Requirements: • Justification of Specification • Source of primary reference standards and its link to secondary and working standard • Container Closure System DRAP Requirements: • No such information regarding reference standard is required.

  13. Active Pharmaceutical ingredient WHO Requirements: • Stability • Stability studies of 3 consecutive batches at acc./inter. & long term conditions, Stability Summary and Conclusions • Proposed storage statement and re-test period DRAP Requirements: • Only stability of FPP is required. No information is required about stability of API(s)

  14. Active Pharmaceutical ingredient WHO Requirements: • Post-approval Stability Protocol and Stability Commitment • Stability Data • Actual stability results • Summary of analytical procedures and validation DRAP Requirements: • No stability data is required for API.

More Related